2017 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The dossier concerns the 2017 discharge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The amendments address refusing, postponing or granting discharge, budget implementation and payment appropriation rates, key performance indicators and strategic objectives, synergies with other Union agencies and shared premises in Lisbon, publication of vacancy notices and associated translation costs, electronic procurement tools, and data collection, validation and quality assurance following Internal Audit Service recommendations.